Today we have a roundup of Atrial Fibrillation Awareness Month stories for you: In her EP Lab DigestPatient Perspective column for this month, StopAfib.org founder Mellanie True Hills summarized the atrial fibrillation stroke prevention report produced by the Afib Optimal Treatment Task Force. There is a lot of great information for patients in this article. …
Read More
The Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for assessing afib stroke and …
Read More
The June issue of EP Lab Digest featured an interview with StopAfib.org founder Mellanie True Hills about the recent launch of the Global Atrial Fibrillation Patient Charter and the Sign Against Stroke in Atrial Fibrillation Campaign at the World Congress of Cardiology in Dubai. The Global AF Patient Charter focused on five critical recommendations that could …
Read More
On May 9th, StopAfib.org will join with the Heart Rhythm Society for a citywide event in Boston kicking off "Cardiac Arrhythmia Awareness Month" in Massachusetts. The event, from 9:00 a.m. to 4:00 p.m. at Boston City Hall Plaza, will raise awareness of the signs and symptoms of potentially life-threatening heart rhythm disorders such as atrial …
Read More
StopAfib.org had the great privilege of participating in the launch of the Global Atrial Fibrillation Patient Charter and the Sign Against Stroke in Atrial Fibrillation campaign at the World Congress of Cardiology in Dubai. To learn more about this independent patient charter, which StopAfib.org participated in developing, and to sign the charter, see: Global Atrial …
Read More
Mellanie True Hills, founder of StopAfib.org, spoke at the Fifth Annual Western Atrial Fibrillation Symposium medical conference. Her remarks are summarized in her patient perspective column in the April 2012 issue of EP Lab Digest. See: How Social Media Helps Educate Afib Patients: An Atrial Fibrillation Patient Perspective Published in EP Lab Digest, April, 2012
Read More
Recently, StopAfib.org partnered with the Cleveland Clinic to give you an opportunity to chat live with three of their atrial fibrillation experts, Dr. Walid Saliba, Dr Mandeep Bhargava, and Dr. David Van Wagoner, who were joined by StopAfib.org founder Mellanie True Hills. The transcript of our afib community chat with these atrial fibrillation experts from …
Read More
Atrial fibrillation is the most common irregular heart rhythm that starts in the atria. While it is often a mere annoyance, it can also be responsible for life-threatening medical emergencies that result in cardiac arrest, stroke and sudden death. Take advantage of the opportunity to get your atrial fibrillation questions answered by afib experts from …
Read More
In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the …
Read More
At Boston Atrial Fibrillation Symposium 2012, Dr. Hugh Calkins, electrophysiologist at Johns Hopkins, presented the new 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, which will replace the original guidelines that were published in 2007. Instead of simply rewriting sections that have changed, the writing committee, which was made up …
Read More